Peptides For Sale
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Semaglutide | D - Poor Tentative rating: based on only 4 samples of Semaglutide from Peptides For Sale, Finnrick has limited confidence in this rating. More tests would be helpful. | 4 | 4.6 | 3.6 | 6.0 | 27 Feb 2025 | 20 Mar 2025 | |
| BPC-157 | E - Bad Tentative rating: based on only 4 samples of BPC-157 from Peptides For Sale, Finnrick has limited confidence in this rating. More tests would be helpful. | 4 | 2.0 | 2.0 | 2.0 | 2 Mar 2025 | 20 Mar 2025 | |
| CJC-1295 | E - Bad Tentative rating: based on only 4 samples of CJC-1295 from Peptides For Sale, Finnrick has limited confidence in this rating. More tests would be helpful. | 4 | 2.0 | 2.0 | 2.0 | 28 Feb 2025 | 20 Mar 2025 | |
| Ipamorelin | E - Bad Tentative rating: based on only 4 samples of Ipamorelin from Peptides For Sale, Finnrick has limited confidence in this rating. More tests would be helpful. | 4 | 3.0 | 2.3 | 3.3 | 27 Feb 2025 | 20 Mar 2025 | |
| Melanotan II | E - Bad Tentative rating: based on only 5 samples of Melanotan II from Peptides For Sale, Finnrick has limited confidence in this rating. More tests would be helpful. | 5 | 3.6 | 3.5 | 3.7 | 27 Feb 2025 | 20 Mar 2025 | |
Most recent Peptides For Sale tests
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 20 Mar 2025 | BPC-157 | 2.0 | 5mg | ⚠️ Sample does not contain BPC-157 Identity Failed Vial contains Ipamorelin | 014 | White Label / Yellow Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. | ||
| 20 Mar 2025 | CJC-1295 | 2.0 | 5mg | ⚠️ Sample does not contain CJC-1295 Identity FAILED Vial contains Ipamorelin modified with terminal glycine. CJC-1295 with DAC not detected | 009 | White Label / Purple Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. | ||
| 20 Mar 2025 | CJC-1295 | 2.0 | 5mg | ⚠️ Sample does not contain CJC-1295 Identity FAILED Vial contains Ipamorelin modified with terminal glycine. CJC-1295 with DAC not detected | 009 | White Label / Purple Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. | ||
| 20 Mar 2025 | Ipamorelin | 2.3 The amount of Ipamorelin is too low as compared to glycine modified Ipamorelin | 5mg | 1.320mg | -73.6% | 1.54% | 015 | White Label / Pink Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. |
| 20 Mar 2025 | Melanotan II | 3.6 | 10mg | 3.620mg | -63.8% | 98.17% | 016 | White Label / Yellow Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. |
| 20 Mar 2025 | Melanotan II | 3.7 | 10mg | 3.290mg | -67.1% | 98.26% | 016 | White Label / Yellow Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. |
| 20 Mar 2025 | Semaglutide | 6.0 | 5mg | 2.790mg | -44.2% | 99.63% | 017 | White Label / White Cap | Lab B | Finnrick This sample was ordered by Finnrick directly from the vendor, anonymously or not. |
Corrections
- 7 Apr 2025 (BPC-157)
- Lab A test 5 Mar 2025: updated compound identification, removed purity/quantity. Error in data transcription by Finnrick: compound was incorrectly reported as BPC-157.
- 6 Apr 2025 (CJC-1295)
- Lab A test 28 Feb 2025: updated compound identification, removed purity/quantity. Error in data transcription by Finnrick: compound was incorrectly reported as CJC-1295.